| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Jun-08 | 31-Mar-08 | | Total Revenue | 5,394,000 | 565,000 | 7,503,000 | 1,544,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 5,394,000 | 565,000 | 7,503,000 | 1,544,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,000,000 | (214,000) | 5,968,000 | 918,000 | | Non Recurring | 32,000 | 745,000 |
-
|
-
| | Others | 2,259,000 | 1,070,000 | 806,000 | 468,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,897,000) | (1,036,000) | 729,000 | 158,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,897,000) | (1,036,000) | 729,000 | 158,000 | | Interest Expense | 120,000 | 115,000 | 77,000 | 67,000 | | Income Before Tax | (2,017,000) | (1,151,000) | 652,000 | 91,000 | | Income Tax Expense | (808,000) | (345,000) | 109,000 | (54,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,209,000) | (806,000) | 543,000 | 145,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,209,000) | (806,000) | 543,000 | 145,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,209,000) | ($806,000) | $543,000 | $145,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
